Choosing Decentralized Clinical Trials
PPD is dedicated to creating environmental innovations to better predict, measure and identify strategies to reduce the greenhouse gas emissions on clinical trials. We are partnering with stakeholders across the clinical trial spectrum to better understand how we can digitize, decentralize and modernize clinical research to make it more environmentally friendly.
Examining Implementation Timelines For Decentralized Clinical Trials (Dcts)
While DCTs can still enable trials that would otherwise be challenging during the pandemic, many of the potential efficiencies — particularly rapid implementation — can remain out of reach. PPD has DCT strategies built into the protocol from the start, with custom features and functions instead of a one-size-fits-all approach.
Learn more about implementation timelines for decentralized trials.
Building Decentralized Clinical Trials for Patients and Clinicians
The increased implementation of decentralized clinical trials means the industry now has a considerable body of evidence and experience to test the strengths of digital clinical trial models. With the growing amount of data comes the ability to assess how to make trials more effective and efficient, including a closer look at qualitative sponsor, site and patient feedback. To gain further insight into this transformation, PPD explored the experiences that key stakeholders have had when approaching decentralized clinical trials.